Vaiomer is a biotech company specializing in tissue and blood microbiota. It focuses on the molecular interaction between the microbiome and host cells in cardiometabolic diseases. In addition, the company provides a set of methods for metagenomic sequencing in tissues as well as for the quantitation of bacterial rDNA and bacterial translocation markers in blood.